Insight into COVID-19's epidemiology, pathology, and treatment
Heliyon, ISSN: 2405-8440, Vol: 8, Issue: 1, Page: e08799
2022
- 24Citations
- 155Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations24
- Citation Indexes24
- 24
- CrossRef19
- Captures155
- Readers155
- 155
Review Description
The newly emerged 2019 coronavirus disease (COVID-19) has urged scientific and medical communities to focus on epidemiology, pathophysiology, and treatment of SARS-CoV-2. Indeed, little is known about the virus causing this severe acute respiratory syndrome pandemic, coronavirus (SARS-CoV-2). Data already collected on viruses belonging to the coronaviridae family are of interest to improve our knowledge rapidly on this pandemic. The current review aims at delivering insight into the fundamental advances inSARS-CoV-2 epidemiology, pathophysiology, life cycle, and treatment.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2405844022000871; http://dx.doi.org/10.1016/j.heliyon.2022.e08799; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85123164393&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/35071819; https://linkinghub.elsevier.com/retrieve/pii/S2405844022000871; https://dx.doi.org/10.1016/j.heliyon.2022.e08799
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know